KAIMAX 100 UNITS

Product Description:
KAIMAX 100 Units is a premium botulinum toxin type A injection designed for the temporary improvement of moderate to severe glabellar lines in adults aged 19 to 65 years. Originating from the European National Institute, KAIMAX boasts high purity and low immunogenicity risk, ensuring safe and effective treatments for cosmetic and therapeutic applications. This product complies with cGMP standards (FDA, EMA) and is suitable for both fine wrinkle correction and larger muscle treatments.

Ingredients:

• Active Ingredient: Clostridium botulinum toxin type A (100 units)
• Excipients:
  • Human serum albumin (EP) – 0.5 mg
  • Sodium chloride (USP) – 0.9 mg

Benefits:

• Effectively reduces the appearance of moderate to severe glabellar lines caused by repetitive muscle activity.
• High-purity formulation minimizes immunogenicity risks and ensures consistent results.
• Versatile use for wrinkle correction and therapeutic applications involving larger muscles.
• Compliant with international quality standards (FDA, EMA) for patient safety.
• Fast-acting and long-lasting results with minimal downtime.

Instructions/Target Areas:

• Target Areas:
  • Glabellar lines (frown lines between the eyebrows)
  • Larger muscle groups for therapeutic treatments
• Preparation:
  • The lyophilized white or light yellow powder must be reconstituted with physiological saline before use.
  • For 100 units, dilute with 2.5 ml of saline; for 200 units, dilute with 5 ml of saline.
  • Once diluted, the solution should appear colorless, clear, or light yellow.
• Procedure:
  • Administered intramuscularly by a qualified healthcare professional.
  • Dose and injection points should be determined based on the patient’s specific needs.
• Post-Treatment:
  • Avoid lying down or applying pressure to the treated areas for a few hours after injection.
  • Results typically appear within 3–7 days and last 3–6 months.

Specifications:

• Brand Name: KAIMAX
• Active Ingredient: Botulinum toxin type A (strain from the European National Institute)
• Dose: 100 units per vial
• Packaging: Clear glass vial containing lyophilized powder
• Effect Duration: 3–6 months
• Dilution Instructions: 2.5 ml saline for 100 units
• Safety Standards: cGMP-compliant, meeting FDA and EMA requirements

Safety Notes:

• Administer only under the supervision of a qualified healthcare professional.
• Not suitable for individuals who are pregnant, breastfeeding, or have certain medical conditions.
• Possible side effects may include temporary redness, swelling, or bruising at the injection site.
• Discuss your medical history and treatment goals with your healthcare provider before use.